MedTrace Logo

ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers

NCT04367857 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-04-08

No results posted yet for this study

Summary

The novel coronavirus (SARS-CoV-2) has spread all around the world and testing has posed a challenge globally. Health care providers are highly exposed and are an important group to test. On top of these concerns, health care workers are also stressed by the needs on responders in the COVID-19 crisis. The investigators will look at different ways to measure how common COVID-19 is among health care workers, how common is the presence of antibodies by serological tests (also known as serostatus). The investigators will describe health worker mental and emotional well-being and their coping strategies in their institutional settings. Lastly, the investigators will describe how knowing serostatus can affect individuals' mental and emotional well-being and how to cope in the midst of the COVID-19 response. This will help to how to better test and help healthcare workers in the COVID-19 pandemic and prepare for possible future outbreaks.

Conditions

  • Covid-19
  • Coronavirus Infection
  • Coronavirus

Interventions

OTHER

COVID-19 Serology

Quantitate Serology enzyme-linked immunosorbent assay (ELISA) for COVID-19

BEHAVIORAL

Health Care Worker Survey

The purpose of this survey is to assess how healthcare workers are experiencing and coping with the COVID-19 crisis.

Sponsors & Collaborators

Principal Investigators

  • Magdalena Sobieszczyk, MD, MPH · Columbia University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-18
Primary Completion
2027-02-28
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04367857 on ClinicalTrials.gov